 Genevieve Sparagna
Concepts (332)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiolipins | 33 | 2023 | 73 | 4.430 |
Why?
| | Myocardium | 20 | 2021 | 965 | 2.030 |
Why?
| | Mitochondria, Heart | 18 | 2022 | 76 | 1.890 |
Why?
| | Mitochondria | 18 | 2023 | 785 | 1.050 |
Why?
| | Heart Failure | 12 | 2016 | 1967 | 0.880 |
Why?
| | Barth Syndrome | 4 | 2022 | 9 | 0.840 |
Why?
| | Phospholipids | 10 | 2023 | 207 | 0.820 |
Why?
| | Linoleic Acid | 6 | 2023 | 41 | 0.810 |
Why?
| | Acyltransferases | 11 | 2022 | 52 | 0.770 |
Why?
| | Myocytes, Cardiac | 7 | 2022 | 470 | 0.610 |
Why?
| | Fatty Acids | 9 | 2023 | 403 | 0.590 |
Why?
| | Rats | 25 | 2022 | 5339 | 0.550 |
Why?
| | Electron Transport Complex III | 7 | 2017 | 12 | 0.540 |
Why?
| | Mitochondria, Liver | 6 | 2017 | 70 | 0.540 |
Why?
| | Diet, High-Fat | 4 | 2021 | 247 | 0.510 |
Why?
| | Palmitic Acid | 3 | 2004 | 38 | 0.490 |
Why?
| | Animal Feed | 2 | 2013 | 55 | 0.460 |
Why?
| | Rats, Inbred SHR | 9 | 2013 | 42 | 0.460 |
Why?
| | Animals | 46 | 2023 | 33152 | 0.420 |
Why?
| | Apoptosis | 7 | 2009 | 2461 | 0.420 |
Why?
| | Hypertrophy, Left Ventricular | 3 | 2009 | 107 | 0.410 |
Why?
| | Berberine | 2 | 2021 | 6 | 0.410 |
Why?
| | Electron Transport Complex IV | 4 | 2012 | 53 | 0.380 |
Why?
| | Calcium | 9 | 2010 | 1151 | 0.360 |
Why?
| | Phospholipases A2, Calcium-Independent | 1 | 2009 | 4 | 0.360 |
Why?
| | Cardiomyopathy, Hypertrophic | 2 | 2021 | 119 | 0.350 |
Why?
| | Saccharomyces cerevisiae | 3 | 2023 | 494 | 0.330 |
Why?
| | Fundulidae | 2 | 2018 | 2 | 0.330 |
Why?
| | Myocardial Reperfusion Injury | 3 | 2013 | 105 | 0.330 |
Why?
| | Oxidation-Reduction | 11 | 2021 | 935 | 0.320 |
Why?
| | Diet | 3 | 2023 | 1143 | 0.310 |
Why?
| | Acclimatization | 2 | 2018 | 133 | 0.300 |
Why?
| | Diabetes, Gestational | 2 | 2021 | 284 | 0.300 |
Why?
| | Dietary Fats | 5 | 2023 | 323 | 0.290 |
Why?
| | Enzyme Inhibitors | 5 | 2013 | 817 | 0.280 |
Why?
| | Electron Transport Complex I | 3 | 2021 | 36 | 0.280 |
Why?
| | Mitochondrial Membrane Transport Proteins | 4 | 2010 | 31 | 0.280 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 2 | 2012 | 171 | 0.270 |
Why?
| | Disease | 1 | 2006 | 87 | 0.270 |
Why?
| | Rats, Sprague-Dawley | 9 | 2009 | 2434 | 0.270 |
Why?
| | Docosahexaenoic Acids | 3 | 2017 | 70 | 0.260 |
Why?
| | Liver | 4 | 2023 | 1803 | 0.260 |
Why?
| | Heart | 4 | 2017 | 630 | 0.260 |
Why?
| | Saccharomyces cerevisiae Proteins | 2 | 2023 | 347 | 0.260 |
Why?
| | Ischemia | 3 | 2018 | 370 | 0.260 |
Why?
| | Transcription Factors | 6 | 2022 | 1567 | 0.260 |
Why?
| | Mitochondrial Membranes | 2 | 2018 | 34 | 0.240 |
Why?
| | Cardiomyopathy, Dilated | 3 | 2014 | 344 | 0.220 |
Why?
| | Body Weight | 6 | 2021 | 923 | 0.220 |
Why?
| | Reactive Oxygen Species | 3 | 2020 | 571 | 0.210 |
Why?
| | Fatty Acids, Unsaturated | 3 | 2021 | 86 | 0.200 |
Why?
| | Mitochondrial Diseases | 1 | 2022 | 79 | 0.200 |
Why?
| | Lipid Metabolism | 3 | 2020 | 473 | 0.190 |
Why?
| | Heart Diseases | 2 | 2021 | 340 | 0.190 |
Why?
| | Palmitates | 1 | 2000 | 18 | 0.190 |
Why?
| | Coenzyme A | 1 | 2020 | 6 | 0.190 |
Why?
| | Maternal-Fetal Exchange | 1 | 2021 | 156 | 0.190 |
Why?
| | Vascular Remodeling | 1 | 2022 | 150 | 0.190 |
Why?
| | Ethanol | 1 | 2004 | 574 | 0.180 |
Why?
| | Male | 24 | 2023 | 57474 | 0.170 |
Why?
| | Physical Conditioning, Animal | 3 | 2008 | 204 | 0.170 |
Why?
| | Heart Ventricles | 3 | 2020 | 725 | 0.170 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2021 | 244 | 0.170 |
Why?
| | Multienzyme Complexes | 2 | 2012 | 64 | 0.170 |
Why?
| | Dietary Supplements | 2 | 2021 | 468 | 0.170 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2021 | 185 | 0.170 |
Why?
| | Cell Culture Techniques | 1 | 2021 | 354 | 0.160 |
Why?
| | Mice | 11 | 2023 | 15446 | 0.160 |
Why?
| | Thermotolerance | 1 | 2018 | 5 | 0.160 |
Why?
| | Animals, Newborn | 5 | 2022 | 804 | 0.160 |
Why?
| | Cardiomyopathies | 1 | 2021 | 298 | 0.160 |
Why?
| | Islets of Langerhans | 2 | 2021 | 739 | 0.160 |
Why?
| | Disease Susceptibility | 1 | 2020 | 330 | 0.160 |
Why?
| | Optic Atrophy, Autosomal Dominant | 1 | 2017 | 1 | 0.160 |
Why?
| | Dynamins | 1 | 2017 | 30 | 0.160 |
Why?
| | Mitochondria, Muscle | 1 | 2018 | 97 | 0.150 |
Why?
| | Intermittent Claudication | 1 | 2018 | 110 | 0.150 |
Why?
| | Mitochondrial Dynamics | 1 | 2017 | 27 | 0.150 |
Why?
| | Eicosapentaenoic Acid | 3 | 2017 | 28 | 0.150 |
Why?
| | Cells, Cultured | 7 | 2021 | 4044 | 0.150 |
Why?
| | Phosphatidylglycerols | 2 | 2023 | 20 | 0.150 |
Why?
| | A Kinase Anchor Proteins | 1 | 2017 | 72 | 0.150 |
Why?
| | Phenotype | 3 | 2022 | 2937 | 0.150 |
Why?
| | Mitochondrial Proteins | 2 | 2016 | 224 | 0.150 |
Why?
| | Cytochrome c Group | 3 | 2001 | 36 | 0.140 |
Why?
| | Blood Pressure | 7 | 2013 | 1656 | 0.140 |
Why?
| | Hypertension | 4 | 2008 | 1199 | 0.140 |
Why?
| | Disease Models, Animal | 7 | 2022 | 3676 | 0.140 |
Why?
| | Female | 17 | 2022 | 61261 | 0.140 |
Why?
| | Sirtuins | 1 | 2016 | 34 | 0.140 |
Why?
| | Signal Transduction | 5 | 2021 | 4688 | 0.140 |
Why?
| | Mitochondrial Trifunctional Protein, alpha Subunit | 1 | 2015 | 1 | 0.140 |
Why?
| | Huntington Disease | 1 | 2016 | 41 | 0.130 |
Why?
| | Temperature | 1 | 2018 | 621 | 0.130 |
Why?
| | Electron Transport | 4 | 2021 | 101 | 0.130 |
Why?
| | Gene Expression | 4 | 2021 | 1482 | 0.130 |
Why?
| | Protein Processing, Post-Translational | 1 | 2017 | 408 | 0.130 |
Why?
| | Caspases | 4 | 2013 | 267 | 0.120 |
Why?
| | Linoleoyl-CoA Desaturase | 1 | 2013 | 3 | 0.120 |
Why?
| | Lymphocytes | 1 | 2016 | 346 | 0.120 |
Why?
| | Fatty Liver | 1 | 2016 | 247 | 0.120 |
Why?
| | Mice, Transgenic | 4 | 2021 | 2012 | 0.120 |
Why?
| | Spectrometry, Fluorescence | 1 | 1994 | 173 | 0.120 |
Why?
| | Cell Differentiation | 1 | 2021 | 1746 | 0.120 |
Why?
| | Oleic Acid | 3 | 2022 | 34 | 0.120 |
Why?
| | Mice, Inbred C57BL | 5 | 2021 | 4887 | 0.110 |
Why?
| | Aging | 3 | 2008 | 1675 | 0.110 |
Why?
| | Peripheral Arterial Disease | 1 | 2018 | 378 | 0.110 |
Why?
| | Safflower Oil | 1 | 2012 | 7 | 0.110 |
Why?
| | Echocardiography | 5 | 2020 | 556 | 0.110 |
Why?
| | Lysophospholipids | 2 | 2012 | 66 | 0.110 |
Why?
| | Citrate (si)-Synthase | 3 | 2007 | 49 | 0.110 |
Why?
| | Electron Transport Complex II | 1 | 2011 | 24 | 0.100 |
Why?
| | Time Factors | 4 | 2009 | 6368 | 0.100 |
Why?
| | Cryoelectron Microscopy | 1 | 2012 | 142 | 0.100 |
Why?
| | Myocardial Contraction | 1 | 2013 | 338 | 0.100 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2011 | 146 | 0.100 |
Why?
| | Energy Metabolism | 1 | 2016 | 762 | 0.090 |
Why?
| | Carnitine O-Palmitoyltransferase | 2 | 2001 | 47 | 0.090 |
Why?
| | Cardiovascular Diseases | 1 | 2022 | 1795 | 0.090 |
Why?
| | Nutritional Status | 1 | 2013 | 298 | 0.090 |
Why?
| | Humans | 18 | 2022 | 118251 | 0.090 |
Why?
| | Ceramides | 2 | 2001 | 96 | 0.090 |
Why?
| | Persistent Fetal Circulation Syndrome | 1 | 2011 | 132 | 0.090 |
Why?
| | Biological Transport | 5 | 2001 | 380 | 0.090 |
Why?
| | Tissue Survival | 1 | 2009 | 13 | 0.090 |
Why?
| | Fish Oils | 1 | 2009 | 25 | 0.090 |
Why?
| | Diacylglycerol Cholinephosphotransferase | 1 | 2008 | 1 | 0.090 |
Why?
| | Cytidine Diphosphate Diglycerides | 1 | 2008 | 3 | 0.090 |
Why?
| | Transferases (Other Substituted Phosphate Groups) | 1 | 2008 | 3 | 0.090 |
Why?
| | Phosphatidic Acids | 1 | 2008 | 8 | 0.090 |
Why?
| | Glycochenodeoxycholic Acid | 1 | 2008 | 12 | 0.080 |
Why?
| | alpha-Tocopherol | 1 | 2008 | 23 | 0.080 |
Why?
| | Cardiotonic Agents | 1 | 2009 | 127 | 0.080 |
Why?
| | Metabolic Syndrome | 1 | 2013 | 392 | 0.080 |
Why?
| | Rats, Inbred Strains | 1 | 2008 | 394 | 0.080 |
Why?
| | Mass Spectrometry | 2 | 2017 | 670 | 0.080 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2009 | 125 | 0.080 |
Why?
| | Adenosine Triphosphate | 3 | 2016 | 438 | 0.080 |
Why?
| | Superoxides | 2 | 2009 | 195 | 0.080 |
Why?
| | Cytosol | 2 | 2000 | 214 | 0.080 |
Why?
| | Rats, Wistar | 3 | 2017 | 396 | 0.080 |
Why?
| | Molecular Structure | 1 | 2009 | 459 | 0.080 |
Why?
| | Obesity | 2 | 2021 | 2715 | 0.080 |
Why?
| | Calcium-Binding Proteins | 4 | 2008 | 215 | 0.080 |
Why?
| | Rats, Inbred BN | 1 | 2007 | 53 | 0.080 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2013 | 418 | 0.080 |
Why?
| | B-Lymphocytes | 2 | 2022 | 767 | 0.080 |
Why?
| | Phosphatidylethanolamines | 2 | 2017 | 66 | 0.080 |
Why?
| | Blotting, Western | 4 | 2016 | 1186 | 0.070 |
Why?
| | Membrane Potentials | 2 | 2000 | 253 | 0.070 |
Why?
| | Heart Function Tests | 2 | 2020 | 61 | 0.070 |
Why?
| | Phosphatidylcholines | 2 | 2017 | 131 | 0.070 |
Why?
| | Genetic Diseases, X-Linked | 1 | 2006 | 24 | 0.070 |
Why?
| | Disease Progression | 1 | 2013 | 2477 | 0.070 |
Why?
| | Cardiac Output, Low | 1 | 2006 | 68 | 0.070 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 144 | 0.070 |
Why?
| | Hypothyroidism | 1 | 2006 | 68 | 0.070 |
Why?
| | Stress, Physiological | 1 | 2009 | 414 | 0.070 |
Why?
| | Syndrome | 1 | 2006 | 343 | 0.070 |
Why?
| | Cyclosporine | 2 | 2009 | 173 | 0.070 |
Why?
| | Chromatography, Gas | 1 | 2005 | 31 | 0.070 |
Why?
| | RNA, Messenger | 3 | 2020 | 2657 | 0.070 |
Why?
| | Pregnancy | 3 | 2022 | 5671 | 0.070 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2005 | 131 | 0.060 |
Why?
| | Reference Standards | 1 | 2005 | 174 | 0.060 |
Why?
| | Protein Kinase C-epsilon | 1 | 2004 | 31 | 0.060 |
Why?
| | Membrane Proteins | 2 | 2008 | 1048 | 0.060 |
Why?
| | Enzyme Activation | 2 | 2012 | 810 | 0.060 |
Why?
| | Linoleic Acids | 1 | 2023 | 4 | 0.060 |
Why?
| | Oxygen Consumption | 2 | 2021 | 585 | 0.060 |
Why?
| | Cell Respiration | 2 | 2017 | 76 | 0.060 |
Why?
| | Kinetics | 3 | 1998 | 1623 | 0.060 |
Why?
| | Coronary Circulation | 1 | 2003 | 121 | 0.060 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2007 | 374 | 0.060 |
Why?
| | Caspase 3 | 2 | 2002 | 240 | 0.060 |
Why?
| | Models, Cardiovascular | 1 | 2004 | 179 | 0.060 |
Why?
| | Acyl Coenzyme A | 2 | 2013 | 30 | 0.060 |
Why?
| | Respiration | 1 | 2023 | 184 | 0.060 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2004 | 179 | 0.060 |
Why?
| | Protein Kinase C | 1 | 2004 | 294 | 0.050 |
Why?
| | Glucose | 2 | 2021 | 940 | 0.050 |
Why?
| | Hydrogen Peroxide | 2 | 2020 | 302 | 0.050 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2022 | 139 | 0.050 |
Why?
| | Indomethacin | 1 | 2022 | 75 | 0.050 |
Why?
| | Interleukin-4 | 1 | 2022 | 216 | 0.050 |
Why?
| | Mice, Knockout | 2 | 2020 | 2664 | 0.050 |
Why?
| | Cell Line | 2 | 2021 | 2693 | 0.050 |
Why?
| | Doxycycline | 1 | 2021 | 59 | 0.050 |
Why?
| | Mitochondrial Swelling | 1 | 2000 | 1 | 0.050 |
Why?
| | Phenylephrine | 1 | 2021 | 85 | 0.050 |
Why?
| | Culture Media | 1 | 2021 | 161 | 0.050 |
Why?
| | Myofibrils | 1 | 2021 | 50 | 0.050 |
Why?
| | Child, Preschool | 3 | 2021 | 9448 | 0.050 |
Why?
| | Sarcomeres | 1 | 2021 | 91 | 0.050 |
Why?
| | Ruthenium Red | 2 | 2001 | 8 | 0.050 |
Why?
| | Proto-Oncogene Proteins | 1 | 2004 | 618 | 0.050 |
Why?
| | Caspase Inhibitors | 1 | 2000 | 79 | 0.050 |
Why?
| | Phosphatidylserines | 1 | 2000 | 90 | 0.050 |
Why?
| | Spermine | 2 | 2001 | 28 | 0.050 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2002 | 192 | 0.050 |
Why?
| | Oxidative Phosphorylation | 2 | 2017 | 156 | 0.050 |
Why?
| | Interleukin-10 | 1 | 2022 | 304 | 0.050 |
Why?
| | Gene Knockdown Techniques | 1 | 2021 | 312 | 0.050 |
Why?
| | Ion Channels | 1 | 2000 | 125 | 0.050 |
Why?
| | Respiratory Function Tests | 1 | 2022 | 526 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2004 | 1937 | 0.040 |
Why?
| | Swine | 2 | 2013 | 719 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2022 | 504 | 0.040 |
Why?
| | Pancreas | 1 | 2021 | 281 | 0.040 |
Why?
| | Fibrosis | 1 | 2021 | 480 | 0.040 |
Why?
| | Ankle Brachial Index | 1 | 2018 | 30 | 0.040 |
Why?
| | Lipopolysaccharides | 1 | 2022 | 857 | 0.040 |
Why?
| | Fluorescent Dyes | 1 | 2000 | 313 | 0.040 |
Why?
| | Lipids | 2 | 2012 | 591 | 0.040 |
Why?
| | DNA, Mitochondrial | 1 | 2020 | 187 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 410 | 0.040 |
Why?
| | Organ Size | 2 | 2009 | 460 | 0.040 |
Why?
| | Aged | 3 | 2018 | 19594 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 1999 | 225 | 0.040 |
Why?
| | Cellular Microenvironment | 1 | 2018 | 78 | 0.040 |
Why?
| | Isolated Heart Preparation | 1 | 2017 | 2 | 0.040 |
Why?
| | Ventricular Remodeling | 1 | 2020 | 228 | 0.040 |
Why?
| | Atrial Natriuretic Factor | 2 | 2009 | 59 | 0.040 |
Why?
| | Insulin | 2 | 2021 | 2157 | 0.040 |
Why?
| | Protein Binding | 2 | 2012 | 1969 | 0.040 |
Why?
| | Enzymes | 1 | 2017 | 66 | 0.040 |
Why?
| | Middle Aged | 3 | 2018 | 27510 | 0.040 |
Why?
| | Adult | 3 | 2022 | 31324 | 0.040 |
Why?
| | Myocardial Infarction | 1 | 2003 | 967 | 0.030 |
Why?
| | Lipogenesis | 1 | 2016 | 66 | 0.030 |
Why?
| | Adiposity | 1 | 2021 | 508 | 0.030 |
Why?
| | Myosin Heavy Chains | 2 | 2009 | 192 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2020 | 1681 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2021 | 810 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 2 | 2008 | 840 | 0.030 |
Why?
| | Hypoxia | 1 | 2022 | 957 | 0.030 |
Why?
| | Child | 3 | 2021 | 19033 | 0.030 |
Why?
| | Herpesvirus 4, Human | 1 | 2016 | 126 | 0.030 |
Why?
| | Hepatocytes | 1 | 2016 | 204 | 0.030 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2021 | 465 | 0.030 |
Why?
| | Infant | 2 | 2021 | 8254 | 0.030 |
Why?
| | Calcium Channels | 3 | 2001 | 149 | 0.030 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2016 | 73 | 0.030 |
Why?
| | Atherosclerosis | 1 | 2018 | 345 | 0.030 |
Why?
| | Glycolysis | 1 | 2016 | 223 | 0.030 |
Why?
| | Egtazic Acid | 1 | 1994 | 40 | 0.030 |
Why?
| | Age Factors | 2 | 2014 | 2990 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2021 | 3156 | 0.030 |
Why?
| | Automation | 1 | 1994 | 76 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2021 | 1590 | 0.030 |
Why?
| | DNA | 1 | 2001 | 1385 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2020 | 1167 | 0.030 |
Why?
| | Ventricular Function, Left | 2 | 2009 | 468 | 0.030 |
Why?
| | Models, Biological | 1 | 2021 | 1701 | 0.030 |
Why?
| | Cytochrome Reductases | 1 | 2012 | 3 | 0.030 |
Why?
| | Mitochondrial Trifunctional Protein | 1 | 2012 | 1 | 0.030 |
Why?
| | Palmitoyl Coenzyme A | 1 | 2012 | 2 | 0.030 |
Why?
| | Phospholipases | 1 | 2012 | 13 | 0.030 |
Why?
| | Proteolipids | 1 | 2012 | 28 | 0.030 |
Why?
| | Weight Gain | 1 | 2016 | 485 | 0.030 |
Why?
| | Ubiquinone | 1 | 2012 | 23 | 0.030 |
Why?
| | Swine, Miniature | 1 | 2013 | 70 | 0.030 |
Why?
| | Thyroxine | 1 | 2012 | 62 | 0.030 |
Why?
| | Microscopy, Electron | 1 | 2012 | 412 | 0.030 |
Why?
| | Protein Structure, Quaternary | 1 | 2012 | 115 | 0.030 |
Why?
| | Sequence Alignment | 1 | 2012 | 334 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2014 | 5230 | 0.030 |
Why?
| | Substrate Specificity | 1 | 2012 | 369 | 0.030 |
Why?
| | Subcellular Fractions | 1 | 2011 | 83 | 0.030 |
Why?
| | Antioxidants | 2 | 2008 | 564 | 0.020 |
Why?
| | MAP Kinase Signaling System | 1 | 2013 | 284 | 0.020 |
Why?
| | Cholesterol | 1 | 2013 | 375 | 0.020 |
Why?
| | Mutation | 1 | 2021 | 3435 | 0.020 |
Why?
| | Structure-Activity Relationship | 1 | 2012 | 522 | 0.020 |
Why?
| | Species Specificity | 1 | 2012 | 559 | 0.020 |
Why?
| | Crystallography, X-Ray | 1 | 2012 | 421 | 0.020 |
Why?
| | Superoxide Dismutase | 2 | 2003 | 338 | 0.020 |
Why?
| | RNA Interference | 1 | 2012 | 459 | 0.020 |
Why?
| | Models, Chemical | 1 | 2012 | 274 | 0.020 |
Why?
| | Adolescent | 2 | 2021 | 18364 | 0.020 |
Why?
| | Thromboxane B2 | 1 | 2009 | 27 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2012 | 650 | 0.020 |
Why?
| | Biomarkers | 1 | 2020 | 3567 | 0.020 |
Why?
| | Constriction | 1 | 2009 | 46 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2012 | 822 | 0.020 |
Why?
| | Aorta, Abdominal | 1 | 2009 | 40 | 0.020 |
Why?
| | Arachidonic Acid | 1 | 2009 | 117 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2018 | 1515 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 980 | 0.020 |
Why?
| | Hemodynamics | 1 | 2013 | 1002 | 0.020 |
Why?
| | Thromboxanes | 1 | 2008 | 16 | 0.020 |
Why?
| | Rats, Mutant Strains | 1 | 2008 | 25 | 0.020 |
Why?
| | Cytochromes c | 1 | 2008 | 63 | 0.020 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2011 | 455 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2012 | 2063 | 0.020 |
Why?
| | Phosphorylation | 1 | 2013 | 1622 | 0.020 |
Why?
| | Diet, Fat-Restricted | 1 | 2008 | 76 | 0.020 |
Why?
| | Heart Transplantation | 1 | 2014 | 672 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 4521 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2012 | 2855 | 0.020 |
Why?
| | Dietary Carbohydrates | 1 | 2008 | 157 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2018 | 6541 | 0.020 |
Why?
| | Cell Death | 1 | 2008 | 336 | 0.020 |
Why?
| | Cytokines | 1 | 2013 | 1880 | 0.020 |
Why?
| | Isomerism | 1 | 2005 | 43 | 0.020 |
Why?
| | Cell Size | 1 | 2005 | 83 | 0.020 |
Why?
| | Pulmonary Artery | 1 | 2011 | 1055 | 0.020 |
Why?
| | RNA | 1 | 2011 | 830 | 0.020 |
Why?
| | Proteinuria | 1 | 2005 | 99 | 0.020 |
Why?
| | Cell Separation | 1 | 2005 | 293 | 0.020 |
Why?
| | Exercise Test | 1 | 2007 | 552 | 0.020 |
Why?
| | Leptin | 1 | 2005 | 228 | 0.010 |
Why?
| | Blood Glucose | 1 | 2013 | 1936 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2012 | 2435 | 0.010 |
Why?
| | Ditiocarb | 1 | 2002 | 3 | 0.010 |
Why?
| | Fluoresceins | 1 | 2002 | 47 | 0.010 |
Why?
| | Tibia | 1 | 2003 | 177 | 0.010 |
Why?
| | Survival Analysis | 1 | 2005 | 1262 | 0.010 |
Why?
| | Chelating Agents | 1 | 2002 | 70 | 0.010 |
Why?
| | Calcium Radioisotopes | 1 | 2001 | 3 | 0.010 |
Why?
| | Adenylate Kinase | 1 | 2001 | 29 | 0.010 |
Why?
| | Adenosine Monophosphate | 1 | 2001 | 51 | 0.010 |
Why?
| | Adenosine Diphosphate | 1 | 2001 | 83 | 0.010 |
Why?
| | Chickens | 1 | 2001 | 184 | 0.010 |
Why?
| | Sodium | 1 | 2000 | 200 | 0.010 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2003 | 709 | 0.010 |
Why?
| | Electric Conductivity | 1 | 1998 | 91 | 0.010 |
Why?
| | NF-kappa B | 1 | 2002 | 664 | 0.010 |
Why?
| | Nitric Oxide | 1 | 2002 | 891 | 0.010 |
Why?
| | Proteins | 1 | 2002 | 935 | 0.010 |
Why?
| | Brain | 1 | 1998 | 2481 | 0.000 |
Why?
|
|
Sparagna's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|